Notice of Intent to Sole Source – Roche Diagnostics BenchMark ULTRA Reagents & Consumables
Closed Pre-Solicitation Posted
- Solicitation number
- NOI-OD-26-006334
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Clinical Center intends to sole-source a one-year contract for Roche Ventana BenchMark ULTRA reagents, consumables, and services for immunohistochemistry and in-situ hybridization testing, with a notice-of-intent close date of August 23, 2026. This procurement uses FAR Part 13 Simplified Acquisition Procedures under Subpart 13.106-1(b)(1), which authorizes single-source solicitation when the contracting officer determines only one source is reasonably available for purchases not exceeding the simplified acquisition threshold. The contract is exempt from FAR Part 6 competition requirements.
The contract supports the Division of Laboratory Medicine's Hematology Bone Marrow Pathology and Consultation Service at the NIH Clinical Center, with performance from September 1, 2026 through August 31, 2027. The procurement is classified under NAICS 541690 (Other Scientific and Technical Consulting Services) and PSC 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets).
This is a notice of intent only; no solicitation document will be issued and no quotations will be requested. Interested parties may submit comments regarding the sole-source determination to Ryssa Nix, Contract Specialist, at the NIH Clinical Center Office of Purchasing and Contracts, via email to Ryssa.nix@nih.gov by 12:00 PM EST on August 23, 2026.
Notice text
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
This procurement is for a one-year (09/01/2026 – 08/31/2027) contract for Roche Ventana BenchMark ULTRA reagents, consumables, service for immunohistochemistry (IHC) and in-situ hybridization (ISH) testing. This purchasing agreement is needed to maintain clinically relevant patient testing with Roche branded IHC and ISH materials to meet the need of the DLM’s Hematology Bone Marrow Pathology and Consultation Service.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.
Notice Type: Notice of Intent
NAICS Code: 541690
PSC Code: 6550
Posted Date: 08/11/2026
Close Date: 08/23/2026 12pm EST
End User IC: Clinical Center
POC Name: Ryssa Nix
Email Address: Ryssa.nix@nih.gov
Files
| File | Type | Posted |
|---|---|---|
| NOI to sole source under SAT.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity